News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Some AstraZeneca PLC Investors Want CEO Replaced
April 9, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - Some of AstraZeneca's biggest investors are calling for a radical shake-up of the drugmaker's board and executive team, including the replacement of David Brennan as CEO, the Financial Times reported on Monday.
Twitter
LinkedIn
Facebook
Email
Print
People
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
·
1 min read
·
Heather McKenzie
Opinion
Biopharma Must Cope With The Fetal Bovine Serum Squeeze
February 17, 2026
·
5 min read
·
Tom Kutrubes
Manufacturing
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
February 17, 2026
·
4 min read
·
Nick Paul Taylor
Government
‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements
February 16, 2026
·
2 min read
·
Tristan Manalac
